Mineralys Therapeutics, Inc. ($MLYS)
Filing Information
| Accession Number | 0001933414-26-000095 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 30, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
312,372
Total Value
$4,074,923.98
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Common Stock | โ | Jun 26, 2026 | Exercise/Conversion | 104,124 | $13.24 | $1,378,601.76 | 142,524 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Jun 26, 2026 | Sale | 104,124 | $25.90 | $2,696,322.22 | 38,400 | Direct | โ | View Details | |
Chief Commercial Officer | Stock Option | Derivative | Jun 26, 2026 | Exercise/Conversion | 104,124 | $0.00 | $0.00 | 252,876 | Direct | โ | View Details |